SCHEMBL30212852

SCHEMBL30212852

CC(=O)CC(=O)Nc1cccc(C(F)(F)C2(C)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ ALDH1A1 P00352 7/20 0.48
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ MAPT P10636 3/20 0.48
▸ GAA P10253 1/20 0.48
▸ XBP1 P17861 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ HDAC3 O15379 1/20 0.44
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC2 Q92769 1/20 0.44
▸ HDAC10 Q969S8 1/20 0.44
▸ HDAC11 Q96DB2 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24027843 1.00 LMNA (0.50) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL25214857 0.84 LMNA (0.51) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL9429509 0.82 SMN1; SMN2 (0.69) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL30212894 0.82 SMN1; SMN2 (0.69) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL22678507 0.81 SMN1; SMN2 (0.56) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL29408140 0.81 SMN1; SMN2 (0.56) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL22658259 0.79 SMN1; SMN2 (0.53) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL24027840 0.79 RXFP1 (0.54) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL30255954 0.79 RXFP1 (0.54) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL24027845 0.78 LMNA (0.46) LMNASMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149928-A1 IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2023-03-22 — — EP disclosed
CN-115697974-A Imidazole 3-oxide derivative based ACSS2 inhibitors and methods of use thereof 美特波米德有限公司 2023-02-03 — — CN disclosed
Send feedback